FRANZETTI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.196
AS - Asia 1.870
EU - Europa 1.633
SA - Sud America 179
AF - Africa 56
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.944
Nazione #
US - Stati Uniti d'America 2.096
CN - Cina 487
GB - Regno Unito 466
SG - Singapore 443
IT - Italia 395
VN - Vietnam 201
BD - Bangladesh 150
HK - Hong Kong 140
DE - Germania 128
BR - Brasile 127
SE - Svezia 116
IN - India 101
RU - Federazione Russa 100
FR - Francia 95
CA - Canada 74
SA - Arabia Saudita 74
NL - Olanda 60
FI - Finlandia 52
IE - Irlanda 48
TR - Turchia 43
KR - Corea 37
BE - Belgio 28
ID - Indonesia 28
JP - Giappone 27
OM - Oman 26
IR - Iran 24
CO - Colombia 22
RO - Romania 22
UA - Ucraina 22
PL - Polonia 19
CI - Costa d'Avorio 18
AE - Emirati Arabi Uniti 16
DK - Danimarca 15
ES - Italia 15
MX - Messico 15
ZA - Sudafrica 14
AT - Austria 12
EU - Europa 12
PK - Pakistan 12
EC - Ecuador 11
GR - Grecia 10
IQ - Iraq 10
PT - Portogallo 10
UZ - Uzbekistan 10
TH - Thailandia 9
TW - Taiwan 9
AU - Australia 8
AR - Argentina 6
AN - Antille olandesi 5
QA - Qatar 5
CH - Svizzera 4
PH - Filippine 4
TZ - Tanzania 4
CL - Cile 3
ET - Etiopia 3
JO - Giordania 3
MA - Marocco 3
MZ - Mozambico 3
PE - Perù 3
VE - Venezuela 3
AL - Albania 2
BG - Bulgaria 2
BW - Botswana 2
EG - Egitto 2
HR - Croazia 2
KE - Kenya 2
KW - Kuwait 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
PY - Paraguay 2
AO - Angola 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
PR - Porto Rico 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.955
Città #
Southend 405
Singapore 263
Ashburn 257
Chandler 158
Hong Kong 124
Milan 114
San Jose 110
Fairfield 105
Seattle 95
Beijing 92
Wilmington 89
Ann Arbor 75
Houston 69
Redwood City 64
Dallas 62
Dearborn 61
Los Angeles 60
Ho Chi Minh City 58
New York 55
Woodbridge 53
Princeton 51
Toronto 50
Council Bluffs 46
Hanoi 46
Dublin 45
Cambridge 42
Boardman 34
Santa Clara 32
Helsinki 29
Turin 28
Lauterbourg 26
Rome 26
Riyadh 25
Phoenix 24
Nanjing 23
Guangzhou 22
Hangzhou 22
Brussels 21
Des Moines 21
Tokyo 20
Jakarta 19
Abidjan 18
Buffalo 18
Moscow 18
The Dalles 18
Bengaluru 17
Columbus 17
Jeddah 17
Margão 17
Mumbai 17
Shanghai 17
Jinan 15
Redmond 15
Hefei 14
Istanbul 14
Seoul 14
Frankfurt am Main 13
Fremont 13
Medellín 13
Muscat 13
Nuremberg 13
Paris 13
Changsha 12
Falls Church 12
Haiphong 12
Shenyang 12
São Paulo 12
Tianjin 12
Warsaw 11
Da Nang 10
Dong Ket 10
Wuhan 10
Mountain View 9
Athens 8
Coimbatore 8
Colorado Springs 8
Fuzhou 8
Ottawa 8
Silver Spring 8
Somerville 8
Zhengzhou 8
Atlanta 7
Boston 7
Cangzhou 7
Catania 7
Makkah 7
Naples 7
Orem 7
Sakarya 7
Vienna 7
Bisha 6
Bogotá 6
Chicago 6
Dubai 6
Madrid 6
Munich 6
Quanzhou 6
Taipei 6
Amsterdam 5
Bologna 5
Totale 3.652
Nome #
Gastrointestinal basidiobolomycosis: an emerging mycosis difficult to diagnose but curable: Case report and review of the literature 717
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 476
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms 417
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 348
EVALUATION OF VIROLOGICAL RESPONSE TO ANTIRETROVIRAL THERAPY IN PATIENTS CARRYING HIV-1 NON-B SUBTYPES ACCORDING TO BASELINE MUTATIONAL PATTERNS 294
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades 279
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy 254
Transmission of Resistant HIV-1 Variants and Epidemiological Chains in Italian Newly Diagnosed Individuals 239
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype 239
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 223
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors : results from a large observational cohort study (SCOLTA) 210
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy 206
Atazanavir/ritonavir monotherapy : 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 205
Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-Institution retrospective study before and after the introduction of HAART 196
A Simple model of HIV epidemic in Italy: The role of the antiretroviral treatment 195
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy 188
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007–2014 period : a weighted analysis 185
Local and global spatio-temporal dynamics of HIV-1 subtype F1 180
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens 176
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 173
Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics 163
Factors involved in continuance of atazanavir-based regimens : Results from a cohort of HIV1-positive patients 161
Bilateral choroiditis as the only sign of persistent Mycobacterium intracellulare infection following haematogenous spread in an immunocompromised patient 146
Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy 136
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study 110
Insidious clinical presentation of uncommon infective endocarditis caused by Cardiobacterium species 86
Totale 6.202
Categoria #
all - tutte 15.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/2022496 42 35 34 25 41 37 40 22 68 47 26 79
2022/2023564 59 72 45 48 47 94 16 38 72 10 44 19
2023/2024350 24 30 20 14 69 36 19 29 14 22 22 51
2024/2025762 22 56 23 86 61 37 56 73 47 76 76 149
2025/20261.955 190 115 153 143 147 139 343 58 189 124 285 69
Totale 6.202